With 0.91 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.94 million shares. During the session, the Pharmaceutical Retailers company that operates in wider Healthcare sector, reached to the highest price of $1.3785 whereas the lowest price it dropped to was $1.1128. The 52-week range on WGRX shows that it touched its highest point at $7.04 and its lowest point at $0.62 during that stretch.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of WGRX was up-trending over the past week, with a rise of 30.16%, but this was up by 41.72% over a month. Three-month performance dropped to -38.81% while six-month performance fell -54.44%.
Float and Shares Shorts:
At present, 63.14 million WGRX shares are outstanding with a float of 11.64 million shares on hand for trading. On 2025-08-15, short shares totaled 0.5 million, which was 64.999997 higher than short shares on 1752537600. In addition to Dr. Shafaat Pirani Pharm.D. as the firm’s Chief Clinical Officer, Mr. Brian Leonard Norton serves as its Chief Executive Officer.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, WGRX reported revenue of $7790865.0 and operating income of -$5500376.0. The EBITDA in the recently reported quarter was -$4685628.0 and diluted EPS was -$0.11.
